Carlos Carrasco

5:51 pm: Carrasco isn’t expected to miss more than around one week of Spring Training action, reports Tim Healey of Newsday (Twitter link).

1:47 pm: The Mets announced that right-hander Carlos Carrasco underwent surgery yesterday in New York to have a bone fragment removed from his throwing elbow.  No specific timeline was given on Carrasco’s recovery, except that he will “resume baseball activities later this winter.”

2021 was already an injury-riddled season for Carrasco, who tossed only 53 2/3 innings over 12 starts after suffering a torn right hamstring during Spring Training.  Initially projected to miss between 6-8 weeks, Carrasco instead didn’t make his season debut until July 30, and then didn’t look like himself in posting a 6.04 ERA.  Carrasco’s 4.44 SIERA was more flattering, but his 21.1% strikeout was by far his lowest since the 2013 season (when Carrasco tossed only 46 2/3 innings in his first year back after Tommy John surgery).

It could be that the bone fragment was a factor in Carrasco’s lack of results, so with this procedure now in the books, the veteran might be able to return to his old form in 2022.  As non-descript as the wording of the Mets’ press release was, the fact that Carrasco will be able to do some type of offseason prep provides something of a positive view that he’ll be ready for Spring Training.

In the bigger picture, of course, another injury is naturally a concern for a pitcher who is entering his age-35 season and already has a significant history of health issues.  Beyond the Tommy John surgery, Carrasco missed three months of the 2019 season battling leukemia before making a stirring return in September as a reliever out of the Indians’ bullpen, and then pitching well as a starter (2.91 ERA/3.91 SIERA) over 68 innings in 2020.

Carrasco is entering the last guaranteed season of the four-year, $47MM extension he signed with Cleveland in December 2018.  The righty is set to earn $12MM in 2022, and the Mets hold a $14MM club option ($2MM buyout) on Carrasco for 2023 that vests into a guaranteed deal if Carrasco tosses 170 innings next season and finishes the year with a clean bill of health.  After acquiring Carrasco as part of the Francisco Lindor blockbuster last offseason, the Mets are certainly hoping for more in Carrasco’s second year with the team, especially since both Marcus Stroman and Noah Syndergaard could leave in free agency this winter.

New York Mets’ right-hander Carlos Carrasco will begin a rehab assignment tonight, according to the Brooklyn Cyclones, the Mets’ High-A affiliate.

The return of a healthy Carrasco would be a huge boon to a Mets team that is gearing up for a pennant race over the season’s final months. They currently sit atop the NL East, but have both Philadelphia and Atlanta within 3.5 and 4 games, respectively. The rotation, despite an excellent front three in Jacob deGrom, Marcus Stroman and Taijuan Walker, has taken some hits with the losses of David Peterson,Jordan Yamamoto, Thomas Szapucki and Joey Lucchesi to injuries, the latter two being done for the year. As a clear contender, the Mets will surely be looking into making additions at the deadline and were recently connected to Cole Hamels. The status of Carrasco could have an impact on how aggressively the Mets pursue starting pitching.

Acquired in the offseason blockbuster that also brought over Francisco Lindor, the Mets have not yet seen Carrasco take the mound this season. The righty tore his hamstring during Spring Training and has been out since. Carrasco has been through a lot in recent years, having battled leukemia, returning healthy, being traded and then the aforementioned hamstring injury. But when on the mound, he has been a very effective starter. With Cleveland from 2014 to 2020, “Cookie” threw 1004 innings with an ERA of 3.41, K% of 28.1 and a BB% of 5.9%, and accumulated 23.4 fWAR in that span.

The Mets will surely be hoping to have that level of production back in the mix, both for this year’s stretch run and the future, as Carrasco is under contract for 2022 at $12MM, with a $14MM vesting/club option for 2023.

Right-hander Carlos Carrasco was one of several headlining offseason additions for the Mets, who acquired him from Cleveland as part of the teams’ Francisco Lindor trade. Unfortunately for Carrasco and New York, though, he hasn’t been able to contribute at all because of a torn right hamstring he suffered in mid-March. Three months later, Carrasco’s Mets debut still isn’t imminent.

Manager Luis Rojas told Anthony DiComo of MLB.com and other reporters on Wednesday that Carrasco is no longer throwing off the slope of the mound – which he was doing last week. While Rojas said “[t]here is no reinjury or anything like that,” he added that Carrasco needs “more strength in that hamstring before we ramp up his baseball progression.”

There’s no timetable for Carrasco’s return, Tim Healey of Newsday tweets, which is a tough blow for a Mets team that on May 27 shut down rehabbing starter Noah Syndergaard for six weeks because of his elbow. Both Carrasco and Syndergaard were supposed to be key complements to ace Jacob deGrom this year, but the club has instead relied on Marcus Stroman and Taijuan Walker in those roles. Stroman and Walker have been terrific, though the Mets’ rotation could use reinforcements after their top three. After all, David Peterson has gone through a difficult year after a promising rookie effort in 2020, while Joey Lucchesi has a 5.79 ERA and hasn’t lasted more than 4 2/3 frames in any of his outings.

If the Mets aren’t able to count on Carrasco or Syndergaard, it could lead them to make other rotation plans leading up to the July 30 trade deadline. The Mets are in first place by 2 1/2 games in the National League East, so they’re lining up as buyers right now.